Literature DB >> 34074316

Correction to: Growth in ataxia telangiectasia.

Valerie A I Natale1, Tim J Cole2, Cynthia Rothblum-Oviatt3, Jennifer Wright4, Thomas O Crawford5, Maureen A Lefton-Greif6, Sharon A McGrath-Morrow7,8, Haley Schlechter8, Howard M Lederman4.   

Abstract

Entities:  

Year:  2021        PMID: 34074316      PMCID: PMC8170954          DOI: 10.1186/s13023-021-01891-5

Source DB:  PubMed          Journal:  Orphanet J Rare Dis        ISSN: 1750-1172            Impact factor:   4.123


× No keyword cloud information.

Correction to: Orphanet J Rare Dis (2021) 16:123 10.1186/s13023-021-01716-5

Following the publication of the original article [1] the authors became aware of an error in Fig. 7: The labels over the purple bars were unfortunately interchanged.
Fig. 7

Median height z-score at age 10–14 in mild and classic A-T, split by length of survival (compared to CDC data). This age range was chosen to facilitate comparison between the oldest patients in the early death cohort and other patients. Mild: mild A-T (41 data points/19 patients). Longer survival: patients surviving past age 25 (99 data points/35 patients). Early death: patients dying by age 15.0 (16 data points/9 patients)

Median height z-score at age 10–14 in mild and classic A-T, split by length of survival (compared to CDC data). This age range was chosen to facilitate comparison between the oldest patients in the early death cohort and other patients. Mild: mild A-T (41 data points/19 patients). Longer survival: patients surviving past age 25 (99 data points/35 patients). Early death: patients dying by age 15.0 (16 data points/9 patients) − 1.31 corresponds to ‘Longer survival (classic)’, while − 2.88 corresponds to ‘Early death (classic)’. The correct Fig. 7 is included in this Correction and has already been updated in the original article.
  1 in total

1.  Growth in ataxia telangiectasia.

Authors:  Valerie A I Natale; Tim J Cole; Cynthia Rothblum-Oviatt; Jennifer Wright; Thomas O Crawford; Maureen A Lefton-Greif; Sharon A McGrath-Morrow; Haley Schlechter; Howard M Lederman
Journal:  Orphanet J Rare Dis       Date:  2021-03-10       Impact factor: 4.123

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.